04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20...

8
04 May 2020 Strategy India Equity Strategy HSIE Research is also available on Bloomberg ERH HDF <GO> & Thomson Reuters Up too much, too soon We are not fully convinced of the durability of current market up-move (Nifty up 30% since 23 rd March’20) and believe that street has not fully factored in the impact of CoVid-19 induced lockdown. Mar-20 volume/earnings disappointment from large index stocks such as HUVR, RIL and rising CoVid- 19 provisioning for banks are precursors to greater systemic earnings weakness in coming months. Nifty is now down ~20% since pre CoVid-19 highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our assessment CoVid-19 impact on FY21 EPS of HSIE univ could be >30%. Already, FY21 EPS growth est for HSIE coverage has been cut from +20% YoY (pre CoVid-19) to -5%YoY, and we see potential for further cuts. RBI’s rate cut/liquidity measures are not percolating into the system as intended while fiscal measures have been delayed and underwhelming. We continue to recommend a largely quality, value and defensive portfolio bias given ongoing uncertainty and heightened volatility with ~4% allocation to cash. Our key picks are: Bharti, ITC, UNSP, Ultratech, SBI Life, ICICI Bank, Axis Bank. IGL, CDSL. Consensus earnings analysis- negative impact not yet fully priced in Based on our analysis of consensus earnings estimates for Nifty constituents (details pls see pg 5) we believe that street has not yet fully factored the impact of CoVid-19 on corporate earnings. In our earlier note (link here) we estimated a hit of >30% on FY21 aggregate PAT of HSIE univ in a scenario of protracted lockdown and slower return-to-normalcy trajectory. However, till date consensus FY21 Nifty EPS has been cut by ~15% and for FY21 consensus is still building in a growth of 13%YoY. This is optimistic - given the intensity and extent of lockdown FY21 will be a negative earnings growth year. In contrast, HDFC sec has already cut FY21 aggregate PAT est by 26% and we currently expect -5%YoY FY21 PAT growth for HSIE univ. 4QFY20 earnings: disappointments likely to strain market in May’20 Many large sector leaders have posted Mar-20 earnings disappointment on an already muted expectation. Most notably, HUVR’s 7%/2% YoY volume/PAT decline in 4QFY20 (despite a trend run rate till mid Mar’20) clearly points to an underestimation bias, which is likely to unravel as we move through the chunky part of earnings season in May’20. We expect more disappointments than surprises, implying a continuation of cuts in May’20 and a likely pronounced negative price reaction given the recent run up. We expect a continuation of negative mgt commentary w.r.t. CoVid-19 impact on FY21 earnings. Recent uptick- a bear market rally rather than a decisive turnaround We would deem recent mkt surge more as a bear market rally and not a resumption of bull market. Proactive and co-ordinated moves of global central bankers and governments have helped to mend financial market sentiments, but the impact on real economy and corporate earnings seem to be underestimated after current rally, in our view. Varun Lohchab [email protected] +91-22-6171-7334 Abhishek Saraf, CFA [email protected] +91-22-6171-7314 Punit Bahlani [email protected] +91-22-6171-7354

Transcript of 04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20...

Page 1: 04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our assessment CoVid-19 impact

04 May 2020 Strategy

India Equity Strategy

HSIE Research is also available on Bloomberg ERH HDF <GO> & Thomson Reuters

Up too much, too soon

We are not fully convinced of the durability of current market up-move (Nifty

up 30% since 23rd March’20) and believe that street has not fully factored in

the impact of CoVid-19 induced lockdown. Mar-20 volume/earnings

disappointment from large index stocks such as HUVR, RIL and rising CoVid-

19 provisioning for banks are precursors to greater systemic earnings

weakness in coming months. Nifty is now down ~20% since pre CoVid-19

highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our

assessment CoVid-19 impact on FY21 EPS of HSIE univ could be >30%.

Already, FY21 EPS growth est for HSIE coverage has been cut from +20% YoY

(pre CoVid-19) to -5%YoY, and we see potential for further cuts. RBI’s rate

cut/liquidity measures are not percolating into the system as intended while

fiscal measures have been delayed and underwhelming. We continue to

recommend a largely quality, value and defensive portfolio bias given

ongoing uncertainty and heightened volatility with ~4% allocation to cash.

Our key picks are: Bharti, ITC, UNSP, Ultratech, SBI Life, ICICI Bank, Axis

Bank. IGL, CDSL.

Consensus earnings analysis- negative impact not yet fully priced in

Based on our analysis of consensus earnings estimates for Nifty constituents

(details pls see pg 5) we believe that street has not yet fully factored the impact

of CoVid-19 on corporate earnings. In our earlier note (link here) we estimated a

hit of >30% on FY21 aggregate PAT of HSIE univ in a scenario of protracted

lockdown and slower return-to-normalcy trajectory. However, till date

consensus FY21 Nifty EPS has been cut by ~15% and for FY21 consensus is still

building in a growth of 13%YoY. This is optimistic - given the intensity and

extent of lockdown FY21 will be a negative earnings growth year. In contrast,

HDFC sec has already cut FY21 aggregate PAT est by 26% and we currently

expect -5%YoY FY21 PAT growth for HSIE univ.

4QFY20 earnings: disappointments likely to strain market in May’20

Many large sector leaders have posted Mar-20 earnings disappointment on an

already muted expectation. Most notably, HUVR’s 7%/2% YoY volume/PAT

decline in 4QFY20 (despite a trend run rate till mid Mar’20) –clearly points to an

underestimation bias, which is likely to unravel as we move through the chunky

part of earnings season in May’20. We expect more disappointments than

surprises, implying a continuation of cuts in May’20 and a likely pronounced

negative price reaction given the recent run up. We expect a continuation of

negative mgt commentary w.r.t. CoVid-19 impact on FY21 earnings.

Recent uptick- a bear market rally rather than a decisive turnaround

We would deem recent mkt surge more as a bear market rally and not a

resumption of bull market. Proactive and co-ordinated moves of global central

bankers and governments have helped to mend financial market sentiments, but

the impact on real economy and corporate earnings seem to be underestimated

after current rally, in our view.

Varun Lohchab

[email protected]

+91-22-6171-7334

Abhishek Saraf, CFA

[email protected]

+91-22-6171-7314

Punit Bahlani

[email protected]

+91-22-6171-7354

Page 2: 04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our assessment CoVid-19 impact

Page | 2

Strategy

Monetary actions: strong but not seeping through; Fiscal actions: more needed

There has been limited percolation of monetary stimulus to intended entities (for

e.g. TLTRO 1 & 2 have either not reached intended recipients or have not been

duly subscribed). Given prevalent risk aversion among banks and compounding

effect of closure of FTMF credit schemes, we think RBI needs to embark on even

more unconventional monetary toolkit (like TARP, first loss assurance etc.) to

normalize frozen credit markets. Similarly, fiscal measures need to ramp up

materially with more incentives/transfers targeted at smaller businesses,

exporters and discretionary services impacted by Covid-19.

HSIE Model Portfolio: biased towards quality, value and defensive names

Our model portfolio largely leans on a mix of quality, value and defensive

stocks/sectors to navigate the expected environment of uncertain Covid-19

outcomes and heightened market volatility. We also recommend 4% cash

position.

Our key O-wts are the typically defensive Utilities (through NTPC, Power

Grid) and Telecom (through Bharti and 9% weightage in RIL to play telecom

story). Within BFSI we currently prefer insurance more than lenders. SBI Life

and ICICI Pru are key picks for us in the sector. Within lenders we prefer to

position only into large sector leaders such as ICICI Bank, Axis Bank which will

be key beneficiary of polarization in deposits. While we have trimmed our wt in

lenders, given the sharp correction and decline in sector’s index weight, lenders

are still o-wt. We have mild o-wt on Pharmaceuticals – recent runup prevent us

from taking aggressive o-wt in pharma, despite the strong sectoral tailwinds in a

post Covid-19 world. Cement is also a mild o-wt in our portfolio.

Key U-wt: (i) Autos (discretionary demand stress), (ii) Cons Staples (large sector

leaders have runup sharply and we prefer select stocks which offer value i.e.

ITC, UNSP), (iii) Cons Discretionary - clear demand compression, (iv) Metals &

Mining and Energy. Within energy we prefer gas over oil and IGL is a key pick.

Given the recent uptick we prefer to have a mildly u-wt stance on IT Services.

Page 3: 04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our assessment CoVid-19 impact

Page | 3

Strategy

HSIE Model Portfolio

Model

Portfolio Price Rating TP

M Cap

US$ bn

Model port on 050320 P/E P/BV(ABV) ROE EPS Growth

Wt Port Wt Rel wt FY21 E FY22 E FY21 E FY22 E FY21 E FY22 E FY21 E FY22 E

Nifty 9,860

1,405.8 100.0% 100.0% 0 bps

Autos

52.9 5.9% 2.0% -394 bps

Eicher Motors 14,708 REDUCE 13,800 5.3 0.5%

-52 bps 27.1 21.7 3.5 3.1 13.5% 15.0% -15.9% 24.9%

Mahindra &

Mahindra Ltd 367 ADD 410 6.1 1.0%

-104 bps 15.2 11.5 1.1 1.0 7.3% 9.1% -23.2% 32.7%

Hero MotoCorp 2,167 BUY 2,210 5.8 0.9%

-89 bps 19.3 15.7 2.8 2.6 14.8% 17.0% -26.0% 22.8%

Maruti Suzuki

India 5,359 ADD 5,810 21.6 1.9%

-186 bps 38.2 21.2 3.1 2.8 8.2% 13.7% -20.3% 80.1%

Tata Motors 93 NR

4.1 0.8%

-77 bps NM 6.5 0.5 0.5 -0.4% 8.0% NM NM

Bajaj Auto 2,623 ADD 2,695 10.1 0.9% 2.0% 115 bps 19.0 16.6 2.9 2.6 15.7% 16.6% -15.1% 14.8%

Banks and

NBFCs 250.0 35.2% 36.5% 129 bps

Axis Bank 445 BUY 541 16.7 2.9% 4.3% 143 bps 12.8 10.0 1.6 1.3 10.7% 12.4% 83.6% 28.8%

State Bank of

India 191 BUY 316 22.6 1.5% 2.5% 100 bps 8.6 6.8 0.7 0.6 8.2% 9.6% 24.0% 26.6%

HDFC Bank 1,002 NR

73.1 11.3% 11.3% 0 bps 19.3 15.1 2.7 2.3 15.9% 17.2% 6.7% 28.2%

Housing

Development

Finance Corp

1,916 NR

44.2 7.9% 7.9% 0 bps 20.5 15.3 3.2 2.9 13.6% 14.5% -18.4% 34.4%

Kotak Mahindra

Bank 1,357 ADD 1,263 34.6 4.1%

-410 bps 41.9 38.9 4.9 4.4 12.2% 11.7% 1.9% 7.7%

IndusInd Bank 468 ADD 575 4.3 0.8%

-79 bps 11.3 7.9 0.8 0.8 8.1% 10.2% -34.9% 41.9%

Bajaj Finance 2,318 NR

18.6 1.4% 1.0% -38 bps 21.8 16.2 3.6 3.0 19.2% 21.3% 8.9% 34.4%

ICICI Bank 380 BUY 435 32.8 5.4% 7.5% 213 bps 16.7 14.1 2.3 2.0 11.6% 12.5% 68.1% 18.9%

Mahindra &

Mahindra

Financial

166 BUY 240 1.4

1.0% 100 bps 9.5 7.0 0.8 0.8 8.8% 11.2% -5.0% 35.9%

Cholamandalam

Investment &

Finance

Company

159 BUY 251 1.7

1.0% 100 bps 9.5 8.2 1.3 1.2 14.8% 15.0% -1.7% 16.4%

Insurance

28.4 0.8% 3.5% 271 bps

Bajaj Finserv 5,104 NR

10.8 0.8%

-79 bps 14.8 11.8 2.3 2.0 17.5% 18.1% 23.1% 25.2%

SBI Life 727 BUY 1,046 9.7

2.5% 250 bps 52.6 49.3 2.3 2.0 13.5% 15.6% 1.7% 6.7%

ICICI Prudential 412 BUY 460 7.9

1.0% 100 bps 39.4 35.3 2.3 2.0 13.6% 15.2% 34.6% 11.7%

Consumer-

Staples 136.8 10.4% 6.0% -442 bps

ITC 182 BUY 221 29.8 3.3% 4.5% 121 bps 15.3 14.0 3.3 3.1 22.2% 23.1% -4.9% 9.1%

Hindustan

Unilever 2,195 REDUCE 1,969 68.6 5.3%

-528 bps 59.2 52.4 12.3 11.7 34.4% 22.9% 17.1% 12.9%

Nestle India 17,925 REDUCE 14,042 23.0 1.5%

-152 bps 75.4 64.2 65.3 50.4 100.1% 88.6% 15.3% 17.4%

Britannia

Industries 3,166 REDUCE 2,711 10.1 0.3%

-32 bps 51.1 44.4 14.1 11.5 30.3% 28.6% 9.7% 15.2%

United Spirits 537 ADD 586 5.2

1.5% 150 bps 39.2 33.3 7.9 6.4 22.3% 21.1% 14.9% 17.7%

Consumer

Discretionary

(ex-Autos)

35.1 3.4% 2.0% -141 bps

Titan Co 970 ADD 1,080 11.5 0.3% 1.0% 70 bps 59.8 39.2 11.2 9.7 19.6% 26.5% -2.6% 52.8%

Asian Paints 1,759 NR

22.5 3.1%

-312 bps 55.1 45.8 13.5 11.8 26.7% 28.0% 9.2% 20.2%

Aditya Birla

Fashion 116 BUY 180 1.2

1.0% 100 bps 209.8 77.3 5.5 5.1 2.7% 6.9% -71.5% 171.3%

Industrials

(Infra+ Cap

Goods)

25.0 2.8% 4.0% 114 bps

Larsen &

Toubro 898 BUY 1,191 16.8 2.4% 3.0% 61 bps 23.9 12.6 1.7 1.6 11.4% 13.0% -15.5% 90.0%

Adani Ports &

Special

Economic Zone

290 NR

7.8 0.5%

-46 bps 12.1 10.5 2.0 1.7 17.1% 17.1% 7.1% 15.2%

KNR

Constructions 210 BUY 278 0.4

1.0% 100 bps 24.2 11.5 1.7 1.5 7.3% 13.9% -37.6% 109.8%

Page 4: 04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our assessment CoVid-19 impact

Page | 4

Strategy

Model

Portfolio Price Rating TP

M Cap

US$ bn

Model port on 050320 P/E P/BV(ABV) ROE EPS Growth

Wt Port Wt Rel wt FY21 E FY22 E FY21 E FY22 E FY21 E FY22 E FY21 E FY22 E

IT and

Exchanges 186.4 14.1% 13.0% -107 bps

Wipro 191 REDUCE 185 14.5 0.6%

-62 bps 12.2 11.3 1.7 1.5 14.9% 14.2% -8.2% 8.4%

Infosys 716 BUY 680 40.6 6.2% 7.0% 78 bps 19.5 16.9 4.5 4.2 23.2% 25.3% -5.1% 15.5%

HCL

Technologies 544 BUY 525 19.6 1.5% 0.5% -103 bps 14.5 12.4 2.6 2.2 19.1% 19.4% -5.0% 16.9%

Tata

Consultancy

Services

2,014 REDUCE 1,680 100.7 4.9% 2.0% -285 bps 25.5 22.8 9.0 8.8 35.1% 38.9% -8.5% 12.0%

Tech Mahindra 546 BUY 625 7.0 0.9% 2.0% 115 bps 12.9 11.4 2.1 1.9 16.5% 17.4% -12.3% 13.4%

L&T Infotech 1,593 ADD 1,650 3.7

0.5% 50 bps 17.1 14.5 4.1 3.6 26.3% 27.0% 7.9% 18.1%

CDSL 225 BUY 315 0.3

1.0% 100 bps 19.9 17.0 3.0 2.7 15.0% 16.0% 1.7% 17.3%

Energy (Oil &

Gas) 170.9 12.8% 11.0% -176 bps

Reliance

Industries 1,466 Add 1,560 123.7 10.7% 9.0% -170 bps 23.7 17.2 1.9 1.7 8.3% 10.5% -8.2% 38.1%

Bharat

Petroleum Corp 370 Add 385 10.7 0.7%

-67 bps 12.8 11.5 1.8 1.6 14.3% 14.6% 88.3% 11.1%

Indian Oil Corp 84 Add 84 10.6 0.4%

-43 bps NM 9.2 0.7 0.7 -0.3% 7.5% NM NM

Oil & Natural

Gas Corp 80 Add 74 13.4 0.5%

-54 bps 12.1 6.6 0.5 0.5 4.0% 7.5% -58.6% 83.4%

GAIL India 96 Add 95 5.7 0.4%

-42 bps 9.4 45.3 0.9 0.9 10.0% 2.0% -26.8% -79.2%

Indraprastha

Gas 477 Add 504 4.4

1.5% 150 bps 38.9 19.6 6.2 5.1 16.7% 28.6% -18.4% 98.9%

Gujarat Gas 259 Add 273 2.4

0.5% 50 bps 28.0 16.7 4.8 3.9 18.7% 25.8% -20.8% 67.8%

Metals &

Mining 30.8 2.7% 1.0% -167 bps

Hindalco

Industries 130 NR

3.9 0.4%

-44 bps 8.7 6.0 0.4 0.4 5.7% 7.7% -29.3% 44.8%

Tata Steel 298 NR

4.5 0.5%

-52 bps 19.9 6.2 0.5 0.5 3.6% 7.9% -30.0% 221.0%

JSW Steel 181 NR

5.8 0.5%

-46 bps 11.7 7.2 1.1 1.0 9.3% 13.8% 8.9% 61.3%

Vedanta 90 NR

4.4 0.4%

-40 bps 7.6 6.4 0.5 0.6 8.7% 9.9% -13.7% 19.3%

Coal India 149 NR

12.2 0.8% 1.0% 16 bps 5.5 5.1 2.6 2.2 52.3% 45.6% -2.9% 6.0%

Cement

28.7 3.0% 3.5% 53 bps

UltraTech

Cement 3,534 BUY 4,850 13.6 1.0% 2.5% 149 bps 31.9 23.9 2.8 2.6 8.3% 10.2% -15.8% 33.5%

Grasim

Industries 505 NR

4.4 0.5%

-48 bps 10.7 8.9 0.5 0.5 7.6% 8.2% 3.3% 20.2%

Shree Cement 19,768 REDUCE 17,900 9.5 1.5%

-148 bps 69.5 52.0 5.2 4.8 7.6% 9.6% -27.0% 33.7%

JK Cement 1,119 BUY 1,355 1.2

1.0% 100 bps 23.0 17.8 2.6 2.3 11.8% 13.9% -12.0% 29.7%

Chemicals

5.4 0.5% 2.0% 145 bps

UPL 420 NR

4.3 0.5%

-55 bps 10.4 8.6 1.7 1.4 17.3% 17.9% 25.6% 20.1%

Galaxy

Surfactants 1,401 BUY 1,834 0.7

1.0% 100 bps 31.9 16.3 4.3 3.5 14.1% 23.5% -18.0% 95.4%

Alkyl Amines 1,790 BUY 1,380 0.5

1.0% 100 bps 24.5 17.2 6.1 4.8 27.3% 31.2% -9.4% 42.6%

Media

2.0 0.4% 0.0% -35 bps

Zee

Entertainment

Enterprises

159 NR

2.0 0.4%

-35 bps 9.2 8.0 1.3 1.2 15.4% 15.8% -4.1% 15.0%

Pharma

35.2 3.1% 3.5% 41 bps

Sun

Pharmaceutical

Industries

464 ADD 450 14.8 1.1%

-114 bps 25.0 20.7 2.2 2.0 10.6% 11.4% 2.7% 20.9%

Cipla Ltd/India 590 BUY 600 6.3 0.8% 2.0% 124 bps 25.2 20.8 2.6 2.4 11.0% 12.0% 11.9% 21.1%

Dr Reddy's

Laboratories 3,936 REDUCE 3,330 8.7 1.2%

-119 bps 27.7 22.4 3.8 3.3 14.6% 15.8% 6.7% 23.4%

Torrent Pharma 2,345 ADD 2,405 5.3

1.5% 150 bps 35.4 28.6 6.9 6.1 20.4% 22.5% 20.0% 23.6%

Telecom

41.7 2.9% 4.0% 108 bps

Bharti Airtel 514 NR

37.4 2.6% 4.0% 139 bps 94.2 38.1 3.0 2.8 2.7% 8.0% NM NM

Bharti Infratel 174 NR

4.3 0.3%

-31 bps 10.4 10.0 2.3 2.3 22.0% 22.6% -5.1% 3.7%

Utilities

23.8 2.0% 4.0% 202 bps

NTPC 95 NR

12.5 0.9% 2.0% 105 bps 6.9 6.3 0.8 0.7 11.8% 12.3% 10.0% 9.3%

Power Grid

Corp of India 162 NR

11.3 1.0% 2.0% 97 bps 7.0 6.4 1.2 1.1 17.8% 17.6% 9.4% 8.8%

Cash

0.0% 4.0% 400 bps

Note: For Life Insurance Companies P/EV and ROEV have been considered in place of P/B and ROE Source: Bloomberg Finance L.P and HSIE Research

Page 5: 04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our assessment CoVid-19 impact

Page | 5

Strategy

Nifty Constituents Earnings Analysis (consensus est)

Price as

on

30th

Apr'20

Cut in Cons EPS since

1st Mar '20 Cons EPS est as of 1st Mar '20

Cons EPS est as of 30th Apr

'20

Latest EPS Growth

estimate

FY20 FY21 FY22 FY20 FY21 FY22 FY20 FY21 FY22 FY21 FY22

AUTOS

-21% -35% -19%

6% 51%

Bajaj Auto 2,623 -2% -8% -7% 176 190 208 172 175 195 2% 11%

Eicher Motors 14,708 -6% -18% -15% 762 844 1,029 720 692 877 -4% 27%

Hero MotoCorp 2,167 -4% -15% -11% 165 172 194 157 147 173 -7% 18%

M&M 367 -11% -26% -19% 41 44 50 36 32 40 -11% 25%

Maruti 5,359 -5% -21% -19% 203 247 305 193 195 247 1% 27%

Tata Motors 93 -370% -114% -35% 3 16 22 -8 -2 14 -70% -734%

BFSI

-6% -15% -10%

16% 31%

Axis Bank 445 -35% -13% -5% 35 45 53 23 39 51 72% 31%

Bajaj Finance 2,318 -4% -23% -21% 102 138 181 98 106 143 9% 34%

Bajaj Finserv 5,104 -1% -8% -8% 285 375 469 281 346 433 23% 25%

HDFC 1,916 -1% -3% -1% 115 97 126 114 93 125 -18% 34%

HDFC Bank 1,002 -3% -12% -6% 50 59 71 49 52 67 7% 28%

ICICI Bank 380 -3% -15% -10% 16 29 35 16 24 31 55% 28%

IndusInd Bank 468 -12% -41% -38% 80 104 130 71 61 81 -14% 33%

Kotak Mahindra 1,357 -2% -12% -10% 48 57 68 47 50 61 5% 23%

SBI 191 -6% -19% -13% 22 35 44 21 29 39 38% 35%

CEMENT

2% -13% -8%

4% 29%

Grasim 505 -10% -17% -7% 24 25 31 22 21 29 -5% 42%

Shree Cement 19,768 30% 12% 17% 420 582 674 547 651 789 19% 21%

Ultratech 3,534 -5% -23% -18% 136 168 204 130 130 168 -0.2% 29%

CHEMICALS

-4% -8% -7%

26% 20%

UPL 420 -4% -8% -7% 34 44 52 32 41 49 26% 20%

CONS DISC

-3% -10% -8%

7% 21%

Asian Paints 1,759 -2% -8% -6% 30 35 41 29 32 38 9% 20%

Titan Co 970 -4% -13% -9% 18 23 28 17 20 26 15% 28%

Zee 159 -2% -12% -11% 18 20 22 18 17 20 -4% 15%

CONS STAPLES

-2% -3% -4%

10% 12%

Britannia Ind 3,166 -1% -4% -5% 58 67 77 58 64 73 11% 14%

HUVR 2,195 -0.1% -2% -2% 34 40 47 34 40 46 19% 15%

ITC 182 -2% -4% -4% 12 13 15 12 13 14 5% 11%

Nestle 17,925 -6% -6% -7% 243 279 316 229 263 293 15% 11%

ENERGY

-7% -22% -13%

7% 27%

BPCL 370 -20% -11% -3% 34 43 45 28 38 44 39% 15%

GAIL 96 -6% -17% -18% 13 15 17 13 12 14 -1% 13%

IOC 84 -16% -9% -6% 12 17 19 10 15 18 58% 15%

ONGC 80 -6% -38% -26% 21 22 24 20 14 18 -30% 32%

RIL 1,466 -4% -20% -10% 74 99 117 70 80 105 13% 32%

HEALTHCARE

-1% -2% -1%

17% 15%

Cipla 590 -1% -2% -0.2% 21 24 28 21 24 28 14% 16%

DRL 3,936 -1% -2% -2% 121 151 174 120 148 171 24% 16%

Sun Pharma 464 -2% -2% -2% 19 22 25 18 21 24 16% 15%

INDUSTRIALS

-4% -15% -13%

2% 20%

Adani SEZ 290 -2% -9% -12% 23 26 31 22 24 28 7% 15%

L&T 898 -5% -18% -14% 72 83 98 68 68 84 -0.003% 22%

IT SERVICES

0% -11% -8%

-2% 12%

HCL Tech 544 0.3% -5% -4% 40 44 48 40 42 46 5% 11%

Infosys 716 0.3% -11% -9% 39 43 47 39 38 43 -1% 12%

TCS 2,014 -0.1% -12% -8% 87 95 104 87 84 95 -3% 13%

Tech M 546 -1% -12% -10% 49 55 62 49 49 55 0% 14%

Wipro 191 0.1% -12% -10% 17 18 19 17 16 17 -8% 9%

Page 6: 04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our assessment CoVid-19 impact

Page | 6

Strategy

Price as

on

30th

Apr'20

Cut in Cons EPS since

1st Mar '20 Cons EPS est as of 1st Mar '20

Cons EPS est as of 30th Apr

'20

Latest EPS Growth

estimate

FY20 FY21 FY22 FY20 FY21 FY22 FY20 FY21 FY22 FY21 FY22

METALS & MINING

-6% -28% -14%

-9% 31%

Coal India 149 -1% -8% -7% 28 30 31 28 27 29 -3% 6%

Hindalco 130 -1% -32% -10% 21 22 24 21 15 22 -29% 45%

JSW Steel 181 -5% -35% -12% 15 24 28 14 15 25 9% 61%

Tata Steel 298 -23% -73% -24% 28 56 63 21 15 48 -30% 221%

Vedanta 90 -16% -30% -27% 16 17 19 14 12 14 -14% 19%

TELECOM

-128% -16% -10%

642% 74%

Bharti Airtel 514 -60% -26% -12% -11 7 15 -5 5 14 -221% 148%

Bharti Infratel 174 1% -2% -2% 18 17 18 18 17 17 -5% 4%

UTILITIES

-2% -2% -1%

10% 9%

NTPC 95 -4% -4% -1% 13 14 15 13 14 15 10% 9%

Power Grid 162 -1% -1% 1% 21 23 25 21 23 25 9% 9%

Nifty 9,860 -6% -15% -8% 572 690 804 539 590 741 9% 26%

Source: Bloomberg Finance L.P. Above analysis is based on consensus estimates movement till 30th April 2020 and price as of that date

Sector level trend in EPS movement and EPS growth is aggregated estimtes from sectoral components

Mar-20 Scorecard till date

Company Name Period PAT/APAT Growth

Estimate

PAT/APAT Growth

Reported

AU Small Finance Bank 4Q FY20 4.9% -40%

Axis Bank 4Q FY20 -25.2% NM

IndusInd Bank 4Q FY20 -71.3% -76.8%

Hindustan Unilever 4Q FY20 8.0% -7.6%

Tech Mahindra 4Q FY20 -10.8% -10.9%

Hexaware 4Q FY20 -2.6% 4.3%

Wipro 4Q FY20 -2.6% -5.3%

Mindtree 4Q FY20 2.7% 4.7%

Tata Consultancy Services 4Q FY20 -0.1% -0.8%

Infosys 4Q FY20 -4.3% 1.0%

Reliance Industries 4Q FY20 -3.5% -16.8%

Ambuja Cement 1Q CY20 28.4% 20.0%

ACC 1Q CY20 8.3% 18.2%

Source: HSIE Research; Company reports

Page 7: 04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our assessment CoVid-19 impact

Page | 7

Strategy

HSLIE Research Team

INDUSTRY ANALYST EMAIL ID PHONE NO.

Head - Research (Consumer, Strategy) Varun Lohchab [email protected] +91-22-6171-7334

Autos, Logistics, Aviation Aditya Makharia

Mansi Lall

[email protected]

[email protected]

+91-22-6171-7316

+91-22-6171-7357

AMCs, Brokerages, Insurance Madhukar Ladha [email protected] +91-22-6171-7323

BFSI, Strategy Abhishek Saraf, CFA

Punit Bahlani

[email protected]

[email protected]

+91-22-6171-7314

+91-22-6171-7354

Banks Darpin Shah

Aakash Dattani

[email protected]

[email protected]

+91-22-6171-7328

+91-22-6171-7337

Cement Rajesh Ravi

Saurabh Dugar

[email protected]

[email protected]

+91-22-6171-7352

+91-22-6171-7353

Construction & Infrastructure, Real Estate Parikshit Kandpal

Rohan Rustagi

[email protected]

[email protected]

+91-22-6171-7317

+91-22-6171-7355

Consumer Durables, FMCG Naveen Trivedi

Aditya Sane

[email protected]

[email protected]

+91-22-6171-7324

+91-22-6171-7336

IT Services & Exchanges

Apurva Prasad

Amit Chandra

Vinesh Vala

[email protected]

[email protected]

[email protected]

+91-22-6171-7327

+91-22-6171-7345

+91-22-6171-7332

Oil & Gas, Chemicals

Harshad Katkar

Nilesh Ghuge

Divya Singhal

[email protected]

[email protected]

[email protected]

+91-22-6171-7319

+91-22-6171-7342

+91-22-6171-7348

Pharma Bansi Desai

Karan Shah

[email protected]

[email protected]

+91-22-6171-7341

+91-22-6171-7359

Retail & Fashion Jay Gandhi

Rutvi Chokshi

[email protected]

[email protected]

+91-22-6171-7320

+91-22-6171-7356

Page 8: 04 May 2020 Strategy India Equity Strategy Equity Strategy - May20 - HS… · highs in mid Feb’20 (vs. ~40% decline till mid March), while as per our assessment CoVid-19 impact

Page | 8

Strategy

Disclosure:

Authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the

subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our

compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.

Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative

or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding

the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material

conflict of interest.

Any holding in stock – YES

HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.

Disclaimer:

This report has been prepared by HDFC Securities Ltd and is solely for information of the recipient only. The report must not be used as a singular basis of any

investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor;

readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. Each recipient of this

document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in securities of the companies

referred to in this document (including merits and risks) and should consult their own advisors to determine merits and risks of such investment. The

information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be

reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy,

completeness or correctness. All such information and opinions are subject to change without notice. Descriptions of any company or companies or their

securities mentioned herein are not intended to be complete. HSL is not obliged to update this report for such changes. HSL has the right to make changes and

modifications at any time.

This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen

or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be

contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction.

If this report is inadvertently sent or has reached any person in such country, especially, United States of America, the same should be ignored and brought to

the attention of the sender. This document may not be reproduced, distributed or published in whole or in part, directly or indirectly, for any purposes or in

any manner.

Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or

price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively

assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security.

This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report

should not be construed as an invitation or solicitation to do business with HSL. HSL may from time to time solicit from, or perform broking, or other services

for, any company mentioned in this mail and/or its attachments.

HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of

the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a

market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any

other potential conflict of interests with respect to any recommendation and other related information and opinions.

HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments

made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates,

diminution in the NAVs, reduction in the dividend or income, etc.

HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt

in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations

described in this report.

HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject

company for any other assignment in the past twelve months.

HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t

date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage

services or other advisory service in a merger or specific transaction in the normal course of business.

HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with

preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this

report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may

have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.

Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of

the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report.

HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg

(East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: [email protected] Phone: (022)

3045 3600

HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg. No. POP: 11092018; IRDA

Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI Investment Adviser Reg. No.: INA000011538; CIN -

U67120MH2000PLC152193

HDFC securities

Institutional Equities

Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park,

Senapati Bapat Marg, Lower Parel, Mumbai - 400 013

Board: +91-22-6171-7330 www.hdfcsec.com